A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Fostamatinib

Fostamatinib 100mg once daily

Trial Locations (26)

Unknown

Research Site, Hong Kong

Research Site, Hong Kong

Research Site, Fukuoka

Research Site, Kitakyushu-shi

Research Site, Sapporo

Research Site, Kato-shi

Research Site, Sendai

Research Site, Nagasaki

Research Site, Omura-shi

Research Site, Sasebo-shi

Research Site, Okayama

Research Site, Tomigusuku-shi

Research Site, Hamamatsu

Research Site, Itabashi-ku

Research Site, Shinjuku-ku

Research Site, Anyang-si

Research Site, Gwangju

Research Site, Incheon

Research Site, Seoul

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Taipei

Research Site, Singapore

Research Site, Bangkok

Research Site, Hanoi

Research Site, Ho Chi Minh City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY